Skip to main content
Premium Trial:

Request an Annual Quote

Abcodia, AIT Collaborate to Validate Cancer Biomarkers

NEW YORK (GenomeWeb News) – UK cancer biomarker firm Abcodia today announced a collaboration with the Austrian Institute of Technology to validate biomarkers for the early detection of lung and colorectal cancers.

Accessing a longitudinal collection of serum samples derived from a population cohort involved in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), Abcodia and AIT will design longitudinal studies to validate panels of biomarkers.

UKCTOCS is a randomized controlled trial for assessing the effect of screening on mortality.

"Abcodia's expertise in longitudinal designs using the UKCTOCS sample bank, knowledge of cancer screening, and links with other commercial companies will prove invaluable in helping us advance our early stage markers toward commercialization and clinical use," Martin Weber, head of the business unit at AIT, said in a statement.

Abcodia COO Chris Hodkinson said that AIT has filed patents for tumor biomarkers in lung and colorectal cancer, and through the two entities' collaboration, he hopes the biomarkers can be advanced for use in cancer screening.

Financial and other terms of the collaboration were not disclosed.

Last week, Cancer Research UK's commercial arm, Cancer Research Technology said it is partnering with Abcodia to develop blood tests for detecting early stage cancers.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.